Vivani Medical, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for VANI, updated each market day.
VANI AI Sentiment
AI sees no strong directional signal for Vivani Medical, Inc. Common Stock stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Vivani Medical, Inc. Common Stock
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
Sector
Exchange
Market Cap
$88,033,715
Cap Tier
Employees
36
Headquarters
ALAMEDA, CA
Listed Since
Aug. 31, 2022
Website
VANI Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
VANI Volatility
Vivani Medical, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
